ITMCTR2000003697尚未招募4 期
Multi-center, Randomized, Double Blind and Placebo Controlled Clinical Trial on the Efficacy and Safety of Jinhua Qinggan Granules (JHQG) for the Treatment of COVID-19 Patients.
Center for Bioequivalence Studies and Clinical Research,Beijing Hospital of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional study
入排标准
- 年龄范围
- 18 至 75(—)
- 性别
- All
入选标准
- •1. Aged 18-75 years male and female;
- •2. Confirmed Coronavirus infection by real time RT-PCR;
- •3. Mild cases of Coronavirus having main symptoms with minimum 2 grade (as mentioned in 7.1.2);
- •4. The subject has signed the informed consent form.
排除标准
- •1. Patients with moderate or critical Coronavirus infection confirmed by real time RT-PCR (rRT-PCR); cases meeting any of the following criteria:
- •(1) Lung lesions;
- •(2) Respiratory failure and requiring mechanical ventilation;
- •(3) Shock;
- •(4) With other organ failure that requires ICU cares;
- •2. Severe primary health conditions associated with cardiovascular, cerebrovascular, pulmonary, hepatic, renal, endocrine and hematological diseases, hematopoietic system (above grade II of cardiac function; ALT & AST are 1.5 times higher than the normal value; Creatinine above the upper limit of normal value) and mental illness or serious diseases affecting their survival, such as cancer or AIDS;
- •3. With severe cardiopulmonary dysfunction, cardiopulmonary insufficiency;
- •4. Subjects, who took other antiviral, antibacterial, cough relieving, expectorant and antiasthmatic drugs within 3 days prior to the visit (including ß2 receptor agonists, anticholinergic agents, theophylline drugs, glucocorticoids, expectorant and Chinese Medicine.);
- •5. Allergic individuals and those who are known to be allergic to experimental drugs;
- •6. Pregnant women, lactating women or fertile women who are ready to conceive in 3 months;
- •7. Subject, who has participated in the past 1 month in another clinical study;
- •8. Subjects who are not suitable for the clinical trial based on investigators judgment.
研究者
相似试验
进行中(未招募)
1 期
Multicenter, randomized, double-blind, and placebo-controlled clinical trial to assess the efficacy and safety of donepezil versus placebo in mild cognitive impairment associated with Parkinson's disease.Parkinson's diseaseCTIS2024-510959-35-00Fundacio Institut De Recerca De L Hospital De La Santa Creu I Sant Pau120
招募中
不适用
Therapeutic effect of bipolar electric low frequency electric stimulator on insomniaKCT0002705Crown Medical240
进行中(未招募)
1 期
Multi-centre, Randomised, Double-blind, Placebo-and Entacapone-controlled, Parallel Group Study of the Efficacy, Safety and Tolerability of E2007 in Levodopa Treated Parkinson s Disease Patients with Motor Fluctuations. - E2007-G000-309EUCTR2006-002937-20-ITEISAI LTD UK900
进行中(未招募)
1 期
Pilot Study to investigate Safety and Efficacy of 8 weeks Treatment of Actinic Keratosis with DFD-07 CreamActinic Keratosis (AK)EUCTR2015-003804-21-DEPromius Pharma LLC
进行中(未招募)
不适用
Multi-Center, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Efficacy of Teikoku Tulobuterol Tape in Adults with Bronchial AsthmaBronchial Asthma (persistent)EUCTR2005-003370-15-EETeikoku Pharma USA, Inc.120
